Neurogene, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NGNE Company Description
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
NGNE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NGNE Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NGNE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NGNE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of NGNE in WallStreetBets Daily Discussion
NGNE News
Recent insights relating to NGNE
CNBC Recommendations
Recent picks made for NGNE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NGNE
Corporate Flights
Flights by private jets registered to NGNE
Our Analysis